Health plan financial performance: 2011-2016
Health plan market trends in the wake of policy and market turbulence
While the media focuses on health plan market volatility, our report shows that health plan financial performance varies heavily, given scale, geography, and population.
How biopharma companies are bolstering R&D pipeline through deal-making
Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. But when choosing from the three main options open to them—licensing, mergers and acquisitions, and joint ventures—what factors should they examine, and do deal types differ in the ways they accelerate development and deliver long-term value?